Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 136

1.

Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.

Goffard A, Callens N, Bartosch B, Wychowski C, Cosset FL, Montpellier C, Dubuisson J.

J Virol. 2005 Jul;79(13):8400-9.

2.

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.

Lavillette D, Morice Y, Germanidis G, Donot P, Soulier A, Pagkalos E, Sakellariou G, Intrator L, Bartosch B, Pawlotsky JM, Cosset FL.

J Virol. 2005 May;79(10):6023-34.

3.

Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1.

Meunier JC, Engle RE, Faulk K, Zhao M, Bartosch B, Alter H, Emerson SU, Cosset FL, Purcell RH, Bukh J.

Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4560-5. Epub 2005 Mar 14.

4.

Analysis of the processing and transmembrane topology of the E2p7 protein of hepatitis C virus.

Isherwood BJ, Patel AH.

J Gen Virol. 2005 Mar;86(Pt 3):667-76.

PMID:
15722527
5.

The tetraspanin web modulates immune-signalling complexes.

Levy S, Shoham T.

Nat Rev Immunol. 2005 Feb;5(2):136-48. Review.

PMID:
15688041
6.

Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells.

Brazzoli M, Helenius A, Foung SK, Houghton M, Abrignani S, Merola M.

Virology. 2005 Feb 5;332(1):438-53.

7.

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.

Lavillette D, Tarr AW, Voisset C, Donot P, Bartosch B, Bain C, Patel AH, Dubuisson J, Ball JK, Cosset FL.

Hepatology. 2005 Feb;41(2):265-74.

PMID:
15660396
8.

High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.

Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J, Vu-Dac N.

J Biol Chem. 2005 Mar 4;280(9):7793-9. Epub 2005 Jan 4.

9.

Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.

Mazzocca A, Sciammetta SC, Carloni V, Cosmi L, Annunziato F, Harada T, Abrignani S, Pinzani M.

J Biol Chem. 2005 Mar 25;280(12):11329-39. Epub 2004 Dec 16.

10.

The many mechanisms of viral membrane fusion proteins.

Earp LJ, Delos SE, Park HE, White JM.

Curr Top Microbiol Immunol. 2005;285:25-66. Review.

PMID:
15609500
11.

A structural perspective of the flavivirus life cycle.

Mukhopadhyay S, Kuhn RJ, Rossmann MG.

Nat Rev Microbiol. 2005 Jan;3(1):13-22. Review.

PMID:
15608696
12.

L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus.

Cormier EG, Durso RJ, Tsamis F, Boussemart L, Manix C, Olson WC, Gardner JP, Dragic T.

Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14067-72. Epub 2004 Sep 15.

13.

Association of hepatitis C virus envelope proteins with exosomes.

Masciopinto F, Giovani C, Campagnoli S, Galli-Stampino L, Colombatto P, Brunetto M, Yen TS, Houghton M, Pileri P, Abrignani S.

Eur J Immunol. 2004 Oct;34(10):2834-42.

14.

Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions.

Keck ZY, Op De Beeck A, Hadlock KG, Xia J, Li TK, Dubuisson J, Foung SK.

J Virol. 2004 Sep;78(17):9224-32.

15.

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.

McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM, Balfe P.

J Virol. 2004 Aug;78(16):8496-505.

16.

Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation.

Ludwig IS, Lekkerkerker AN, Depla E, Bosman F, Musters RJ, Depraetere S, van Kooyk Y, Geijtenbeek TB.

J Virol. 2004 Aug;78(15):8322-32.

17.

Regulation of hepatitis C virus polyprotein processing by signal peptidase involves structural determinants at the p7 sequence junctions.

Carrère-Kremer S, Montpellier C, Lorenzo L, Brulin B, Cocquerel L, Belouzard S, Penin F, Dubuisson J.

J Biol Chem. 2004 Oct 1;279(40):41384-92. Epub 2004 Jul 7.

18.

Neutralizing antibody response during acute and chronic hepatitis C virus infection.

Logvinoff C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, Feinstone SM, Alter H, Rice CM, McKeating JA.

Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10149-54. Epub 2004 Jun 25.

19.

Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins.

Flint M, Logvinoff C, Rice CM, McKeating JA.

J Virol. 2004 Jul;78(13):6875-82.

20.

Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin.

Zhang M, Gaschen B, Blay W, Foley B, Haigwood N, Kuiken C, Korber B.

Glycobiology. 2004 Dec;14(12):1229-46. Epub 2004 Jun 2.

PMID:
15175256

Supplemental Content

Support Center